PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,151,100 | -1.9% | 350,342 | 0.0% | 0.42% | -4.5% |
| Q2 2023 | $2,193,141 | -16.5% | 350,342 | -36.3% | 0.44% | -17.9% |
| Q1 2023 | $2,625,131 | -45.2% | 550,342 | 0.0% | 0.54% | -46.5% |
| Q4 2022 | $4,787,975 | -26.9% | 550,342 | 0.0% | 1.01% | -38.4% |
| Q3 2022 | $6,549,000 | -16.5% | 550,342 | 0.0% | 1.64% | -10.5% |
| Q2 2022 | $7,842,000 | +7.5% | 550,342 | +57.1% | 1.84% | +27.9% |
| Q1 2022 | $7,294,000 | -42.6% | 350,342 | -36.3% | 1.44% | -39.6% |
| Q4 2021 | $12,713,000 | +20.1% | 550,342 | +54.9% | 2.38% | +9.7% |
| Q3 2021 | $10,589,000 | -19.6% | 355,342 | -7.8% | 2.17% | -19.5% |
| Q2 2021 | $13,163,000 | -53.2% | 385,342 | -54.9% | 2.70% | -55.6% |
| Q1 2021 | $28,111,000 | – | 854,684 | – | 6.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |